Trial Profile
Impact of pneumococcal conjugate vaccine on invasive pneumococcal diseases in children less than 5 years of age in Morocco
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Sep 2015
Price :
$35
*
At a glance
- Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary)
- Indications Pneumococcal infections
- Focus Therapeutic Use
- 07 Sep 2015 New trial record